See more : Samart Corporation Public Company Limited (SAMART.BK) Income Statement Analysis – Financial Results
Complete financial analysis of Stratec SE (0RAR.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Stratec SE, a leading company in the Medical – Equipment & Services industry within the Healthcare sector.
- Plascar Participações Industriais S.A. (PLAS3.SA) Income Statement Analysis – Financial Results
- Tokyo Chuo Auction Holdings Limited (1939.HK) Income Statement Analysis – Financial Results
- Bengal & Assam Company Limited (BENGALASM.BO) Income Statement Analysis – Financial Results
- Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria (CRESY) Income Statement Analysis – Financial Results
- Prime Medicine, Inc. (PRME) Income Statement Analysis – Financial Results
Stratec SE (0RAR.L)
About Stratec SE
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 261.91M | 274.63M | 287.34M | 250.10M | 221.64M | 187.82M | 209.76M | 184.91M | 146.89M | 144.86M | 127.95M | 122.42M | 122.20M | 106.73M | 79.59M | 67.53M | 0.00 | 0.00 | 48.42M | 39.21M | 32.81M | 28.12M |
| Cost of Revenue | 197.07M | 195.14M | 199.62M | 181.11M | 169.54M | 134.34M | 142.27M | 123.28M | 91.85M | 99.92M | 86.19M | 82.85M | 59.25M | 53.09M | 43.00M | 32.22M | -30.07M | -36.83M | 25.05M | 20.53M | 18.11M | 16.87M |
| Gross Profit | 64.85M | 79.49M | 87.71M | 68.99M | 52.10M | 53.48M | 67.50M | 61.64M | 55.03M | 44.94M | 41.76M | 39.57M | 62.94M | 53.65M | 36.58M | 35.31M | 30.07M | 36.83M | 23.36M | 18.67M | 14.70M | 11.25M |
| Gross Profit Ratio | 24.76% | 28.94% | 30.53% | 27.58% | 23.51% | 28.47% | 32.18% | 33.33% | 37.47% | 31.02% | 32.64% | 32.32% | 51.51% | 50.26% | 45.97% | 52.29% | 0.00% | 0.00% | 48.26% | 47.63% | 44.80% | 40.00% |
| Research & Development | 9.07M | 6.87M | 9.28M | 7.67M | 5.11M | 9.24M | 10.26M | 8.05M | 8.34M | 5.02M | 5.05M | 2.75M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 19.26M | 18.15M | 18.46M | 18.88M | 17.11M | 16.28M | 20.98M | 15.99M | 11.79M | 11.23M | 8.83M | 8.78M | 0.00 | 25.64M | 20.71M | 13.73M | 0.00 | 0.00 | 11.33M | 9.96M | 0.00 | 0.00 |
| Selling & Marketing | 12.34M | 12.11M | 9.81M | 8.81M | 10.30M | 13.64M | 12.92M | 12.78M | 6.61M | 5.89M | 7.14M | 9.69M | 0.00 | 0.00 | 0.00 | 0.00 | -1.38M | -1.51M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 31.60M | 30.25M | 28.26M | 27.68M | 27.41M | 29.92M | 33.90M | 28.77M | 18.40M | 17.11M | 15.96M | 18.47M | 0.00 | 25.64M | 20.71M | 13.73M | -1.38M | -1.51M | 11.33M | 9.96M | 0.00 | 0.00 |
| Other Expenses | 1.28M | -385.00K | -279.00K | -421.00K | -662.00K | -1.33M | -5.50M | 606.00K | 1.43M | -1.25M | 1.26M | -19.00K | -20.24K | -17.44K | 8.79M | -8.69M | 0.00 | 0.00 | -3.27M | -2.32M | -10.48M | -8.04M |
| Operating Expenses | 41.96M | 36.74M | 37.26M | 34.93M | 31.85M | 37.83M | 38.66M | 37.43M | 28.16M | 20.88M | 22.27M | 21.95M | 41.10M | 36.04M | 29.51M | 5.04M | -1.38M | -1.51M | 8.06M | 7.64M | -10.48M | -8.04M |
| Cost & Expenses | 239.02M | 231.88M | 236.89M | 216.04M | 201.39M | 172.17M | 180.92M | 160.71M | 120.01M | 120.81M | 108.46M | 104.81M | 100.35M | 89.12M | 72.51M | 37.26M | -31.45M | -38.34M | 33.11M | 28.17M | 7.63M | 8.83M |
| Interest Income | 66.00K | 103.00K | 1.00K | 4.00K | 10.00K | 5.00K | 15.00K | 59.00K | 352.00K | 216.00K | 137.00K | 226.00K | 189.31K | 130.13K | 119.69K | 423.00K | 0.00 | 0.00 | 408.75K | 248.68K | 272.38K | 212.00K |
| Interest Expense | 3.99M | 1.90M | 1.43M | 1.11M | 1.03M | 662.00K | 816.00K | 1.04M | 180.00K | 218.00K | 239.00K | 313.00K | 578.95K | 278.94K | 214.25K | 191.00K | 0.00 | 0.00 | 64.16K | 5.62K | 4.34K | 8.00K |
| Depreciation & Amortization | 17.69M | 16.93M | 17.21M | 18.49M | 18.70M | 20.18M | 17.30M | 11.21M | 6.23M | 8.20M | 6.57M | 3.76M | 3.86M | 3.27M | 2.57M | 2.29M | 2.27M | 1.82M | 1.03M | 1.00M | 947.00K | 836.00K |
| EBITDA | 39.82M | 57.53M | 65.45M | 52.59M | 36.09M | 34.86M | 47.04M | 35.06M | 33.59M | 32.47M | 26.12M | 21.55M | 25.28M | 21.10M | 17.89M | 11.90M | 16.98M | 12.76M | 8.20M | 5.69M | 3.72M | 2.64M |
| EBITDA Ratio | 15.20% | 21.38% | 24.03% | 22.02% | 17.08% | 19.88% | 22.61% | 19.20% | 22.79% | 22.42% | 20.49% | 17.64% | 20.92% | 19.77% | 22.47% | 25.16% | 0.00% | 0.00% | 16.52% | 13.96% | 11.35% | 9.37% |
| Operating Income | 22.89M | 41.78M | 50.78M | 32.48M | 19.11M | 15.65M | 28.84M | 24.20M | 26.88M | 24.05M | 19.49M | 17.62M | 21.84M | 17.61M | 7.08M | 30.27M | 31.45M | 38.34M | 15.30M | 11.04M | 25.18M | 19.29M |
| Operating Income Ratio | 8.74% | 15.21% | 17.67% | 12.99% | 8.62% | 8.33% | 13.75% | 13.09% | 18.30% | 16.60% | 15.23% | 14.39% | 17.88% | 16.50% | 8.90% | 44.82% | 0.00% | 0.00% | 31.61% | 28.15% | 76.75% | 68.59% |
| Total Other Income/Expenses | -4.66M | -922.00K | -667.00K | 576.00K | -1.72M | -1.29M | -813.00K | -1.28M | 298.00K | 2.00K | -160.00K | -255.00K | -713.00K | -56.80K | 380.00K | 9.97M | 0.00 | 0.00 | -8.40M | -6.62M | -5.75M | -17.50M |
| Income Before Tax | 18.23M | 39.09M | 46.83M | 33.02M | 18.32M | 14.09M | 28.03M | 22.94M | 27.17M | 24.05M | 19.33M | 17.36M | 21.13M | 17.55M | 15.10M | 14.52M | 0.00 | 0.00 | 6.90M | 4.46M | 2.77M | 1.79M |
| Income Before Tax Ratio | 6.96% | 14.23% | 16.30% | 13.20% | 8.27% | 7.50% | 13.36% | 12.40% | 18.50% | 16.60% | 15.11% | 14.18% | 17.29% | 16.45% | 18.97% | 21.50% | 0.00% | 0.00% | 14.25% | 11.39% | 8.45% | 6.37% |
| Income Tax Expense | 5.16M | 9.87M | 6.87M | 4.59M | 2.23M | 2.98M | 2.39M | 3.36M | 5.09M | 4.29M | 3.86M | 3.39M | 5.85M | 4.51M | 3.43M | 4.53M | 0.00 | 0.00 | -5.85M | -4.88M | -21.32M | -16.81M |
| Net Income | 13.07M | 29.22M | 39.96M | 25.18M | 14.44M | 8.97M | 25.64M | 19.57M | 22.08M | 19.77M | 15.48M | 13.97M | 15.28M | 13.04M | 11.67M | 9.99M | 0.00 | 0.00 | 4.41M | 2.78M | 1.68M | 1.11M |
| Net Income Ratio | 4.99% | 10.64% | 13.91% | 10.07% | 6.52% | 4.78% | 12.22% | 10.58% | 15.03% | 13.65% | 12.10% | 11.41% | 12.51% | 12.22% | 14.67% | 14.80% | 0.00% | 0.00% | 9.11% | 7.09% | 5.13% | 3.95% |
| EPS | 1.07 | 2.41 | 3.30 | 2.42 | 1.34 | 0.75 | 2.16 | 1.65 | 1.87 | 1.68 | 1.32 | 1.06 | 1.32 | 1.14 | 1.03 | 0.54 | 0.00 | 0.00 | 0.43 | 0.28 | 0.17 | 0.11 |
| EPS Diluted | 1.07 | 2.40 | 3.28 | 2.40 | 1.33 | 0.75 | 2.14 | 1.63 | 1.85 | 1.67 | 1.31 | 1.06 | 1.31 | 1.12 | 1.02 | 0.54 | 0.00 | 0.00 | 0.42 | 0.28 | 0.17 | 0.11 |
| Weighted Avg Shares Out | 12.16M | 12.13M | 12.11M | 12.06M | 11.99M | 11.94M | 11.88M | 11.85M | 11.81M | 11.77M | 11.75M | 11.69M | 11.62M | 11.47M | 11.35M | 11.36M | 11.35M | 11.06M | 10.17M | 9.88M | 9.88M | 9.66M |
| Weighted Avg Shares Out (Dil) | 12.16M | 12.17M | 12.18M | 12.15M | 12.06M | 12.03M | 11.98M | 11.94M | 11.92M | 11.83M | 11.78M | 11.75M | 11.71M | 11.67M | 11.43M | 11.39M | 11.48M | 11.38M | 10.50M | 10.05M | 9.92M | 9.67M |
Source: https://incomestatements.info
Category: Stock Reports